---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-201351"
form_type: "8-K"
ticker: "JAGX"
cik: "0001585608"
company_name: "Jaguar Health, Inc."
filed_at: "2025-09-11T23:59:59+00:00"
generated_at: "2026-05-17T06:52:52.927905+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Jaguar Health raises $2.38M via Series N Perpetual Preferred Stock PIPE

## Summary
- Issued ~951 Series N Preferred shares at $2,500 stated value each for aggregate proceeds of $2.38M.
- Series N Preferred non-dividend, non-convertible but exchangeable into common at $1.20 per share after shareholder approval.
- Proceeds to be used for working capital and repayment of certain existing notes.
- Company must seek stockholder approval within 90 days; beneficial ownership capped at 19.99%.
- Registration statement for resale of exchange shares required within 30 days of closing.

## SEC filing metadata
- accession: 0001193125-25-201351
- form_type: 8-K
- ticker: JAGX
- cik: 0001585608
- company_name: Jaguar Health, Inc.
- filed_at: 2025-09-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1585608/000119312525201351/0001193125-25-201351-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1585608/000119312525201351/d947025d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-201351
- JSON: https://secwatch.observer/filing/0001193125-25-201351.json
- Plain text: https://secwatch.observer/filing/0001193125-25-201351.txt

## Key facts
- Equity Issuances
  Jaguar Health, Inc. issued an aggregate of approximately 951 shares (the "Preferred Shares") of Series N Perpetual Preferred Stock of preferred stock to certain investors named therein (collectively, the "Purchasers") for aggregate purchase price of approximately $2.38 million.
  - Security: preferred stock
  - Shares: an aggregate of approximately 951 shares (the "Preferred Shares") of Series N Perpetual Preferred Stock
  - Purchaser: certain investors named therein (collectively, the "Purchasers")
  - Consideration: aggregate purchase price of approximately $2.38 million
  source text: Shares”) of Series N Perpetual Preferred Stock, par value $0.0001 per share, of the Company (“Series N Preferred Stock”), for an aggregate purchase price of approximately $2.38 million (the “Private Placement”). The Private Placement closed on September 10, 2025, subject to customary closing conditions as set forth in the PIPE Purchase Agreements. The Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/1585608/000119312525201351/0001193125-25-201351-index.htm
- Governance Changes
  Jaguar Health, Inc.: Filed Series N Certificate of Designation for preferred stock (effective 2025-09-09).
  - Change: charter amendment
  - Effective: 2025-09-09
  source text: Series N Certificate of Designation As disclosed under Items 1.01 and 3.02 above, in connection with the Private Placement, the Company agreed to issue shares of Series N Preferred Stock to the Purchasers. The preferences, rights, limitations and other matters relating to the Series N Preferred Stock are set forth in the Certificate of Designation, which the Company filed with the Secretary of State of the State of Delaware on September 9, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1585608/000119312525201351/0001193125-25-201351-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.